Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

B Cell Fcγ Receptor IIb Modulates Atherosclerosis in Male and Female Mice by Controlling Adaptive Germinal Center and Innate B-1-Cell Responses.

Bagchi-Chakraborty J, Francis A, Bray T, Masters L, Tsiantoulas D, Nus M, Harrison J, Broekhuizen M, Leggat J, Clatworthy MR, Espéli M, Smith KGC, Binder CJ, Mallat Z, Sage AP.

Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1379-1389. doi: 10.1161/ATVBAHA.118.312272. Epub 2019 May 16.

PMID:
31092015
2.

IgG and Fcγ Receptors in Intestinal Immunity and Inflammation.

Castro-Dopico T, Clatworthy MR.

Front Immunol. 2019 Apr 12;10:805. doi: 10.3389/fimmu.2019.00805. eCollection 2019. Review.

3.

HIF1A and NFAT5 coordinate Na+-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting.

Neubert P, Weichselbaum A, Reitinger C, Schatz V, Schröder A, Ferdinand JR, Simon M, Bär AL, Brochhausen C, Gerlach RG, Tomiuk S, Hammer K, Wagner S, van Zandbergen G, Binger KJ, Müller DN, Kitada K, Clatworthy MR, Kurts C, Titze J, Abdullah Z, Jantsch J.

Autophagy. 2019 Apr 14:1-18. doi: 10.1080/15548627.2019.1596483. [Epub ahead of print]

PMID:
30982460
4.

How to Find a Resident Kidney Macrophage: the Single-Cell Sequencing Solution.

Clatworthy MR.

J Am Soc Nephrol. 2019 May;30(5):715-716. doi: 10.1681/ASN.2019030245. Epub 2019 Apr 4. No abstract available.

PMID:
30948628
5.

Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis.

Castro-Dopico T, Dennison TW, Ferdinand JR, Mathews RJ, Fleming A, Clift D, Stewart BJ, Jing C, Strongili K, Labzin LI, Monk EJM, Saeb-Parsy K, Bryant CE, Clare S, Parkes M, Clatworthy MR.

Immunity. 2019 Apr 16;50(4):1099-1114.e10. doi: 10.1016/j.immuni.2019.02.006. Epub 2019 Mar 12.

6.

Belimumab in kidney transplantation - Authors' reply.

Banham GD, Flint SM, Shanahan DN, Henderson RB, Clatworthy MR.

Lancet. 2019 Mar 2;393(10174):875-876. doi: 10.1016/S0140-6736(18)33066-6. No abstract available.

PMID:
30837145
7.

Selective Disruption of Mitochondrial Thiol Redox State in Cells and In Vivo.

Booty LM, Gawel JM, Cvetko F, Caldwell ST, Hall AR, Mulvey JF, James AM, Hinchy EC, Prime TA, Arndt S, Beninca C, Bright TP, Clatworthy MR, Ferdinand JR, Prag HA, Logan A, Prudent J, Krieg T, Hartley RC, Murphy MP.

Cell Chem Biol. 2019 Mar 21;26(3):449-461.e8. doi: 10.1016/j.chembiol.2018.12.002. Epub 2019 Jan 31.

8.

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis.

Wijeyekoon RS, Kronenberg-Versteeg D, Scott KM, Hayat S, Jones JL, Clatworthy MR, Floto RA, Barker RA, Williams-Gray CH.

Front Neurol. 2018 Oct 16;9:870. doi: 10.3389/fneur.2018.00870. eCollection 2018.

9.

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease.

Scott KM, Kouli A, Yeoh SL, Clatworthy MR, Williams-Gray CH.

Front Neurol. 2018 Oct 1;9:815. doi: 10.3389/fneur.2018.00815. eCollection 2018.

10.

PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner.

Stark AK, Chandra A, Chakraborty K, Alam R, Carbonaro V, Clark J, Sriskantharajah S, Bradley G, Richter AG, Banham-Hall E, Clatworthy MR, Nejentsev S, Hamblin JN, Hessel EM, Condliffe AM, Okkenhaug K.

Nat Commun. 2018 Aug 9;9(1):3174. doi: 10.1038/s41467-018-05674-8.

11.

Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.

Banham GD, Flint SM, Torpey N, Lyons PA, Shanahan DN, Gibson A, Watson CJE, O'Sullivan AM, Chadwick JA, Foster KE, Jones RB, Devey LR, Richards A, Erwig LP, Savage CO, Smith KGC, Henderson RB, Clatworthy MR.

Lancet. 2018 Jun 30;391(10140):2619-2630. doi: 10.1016/S0140-6736(18)30984-X. Epub 2018 Jun 14.

PMID:
29910042
12.

Non-Invasive Multiphoton Imaging of Islets Transplanted Into the Pinna of the NOD Mouse Ear Reveals the Immediate Effect of Anti-CD3 Treatment in Autoimmune Diabetes.

Benson RA, Garcon F, Recino A, Ferdinand JR, Clatworthy MR, Waldmann H, Brewer JM, Okkenhaug K, Cooke A, Garside P, Wållberg M.

Front Immunol. 2018 May 18;9:1006. doi: 10.3389/fimmu.2018.01006. eCollection 2018.

13.

Renal Sodium Gradient Orchestrates a Dynamic Antibacterial Defense Zone.

Berry MR, Mathews RJ, Ferdinand JR, Jing C, Loudon KW, Wlodek E, Dennison TW, Kuper C, Neuhofer W, Clatworthy MR.

Cell. 2017 Aug 24;170(5):860-874.e19. doi: 10.1016/j.cell.2017.07.022. Epub 2017 Aug 10.

14.

Pancreatic allograft thrombosis: Suggestion for a CT grading system and management algorithm.

Hakeem A, Chen J, Iype S, Clatworthy MR, Watson CJE, Godfrey EM, Upponi S, Saeb-Parsy K.

Am J Transplant. 2018 Jan;18(1):163-179. doi: 10.1111/ajt.14433. Epub 2017 Sep 14.

15.

Fcγ Receptors in Solid Organ Transplantation.

Castro-Dopico T, Clatworthy MR.

Curr Transplant Rep. 2016;3(4):284-293. Epub 2016 Oct 3. Review.

16.

Kidney Macrophages: Unique Position Solves a Complex Problem.

Berry M, Clatworthy MR.

Cell. 2016 Aug 11;166(4):799-801. doi: 10.1016/j.cell.2016.07.047.

17.

Local Expansion of Donation After Circulatory Death Kidney Transplant Activity Improves Waitlisted Outcomes and Addresses Inequities of Access to Transplantation.

Mirshekar-Syahkal B, Summers D, Bradbury LL, Aly M, Bardsley V, Berry M, Norris JM, Torpey N, Clatworthy MR, Bradley JA, Pettigrew GJ.

Am J Transplant. 2017 Feb;17(2):390-400. doi: 10.1111/ajt.13968. Epub 2016 Aug 26.

18.

Novel immunotherapeutic strategies to target alloantibody-producing B and plasma cells in transplantation.

Inaba A, Clatworthy MR.

Curr Opin Organ Transplant. 2016 Aug;21(4):419-26. doi: 10.1097/MOT.0000000000000338. Review.

PMID:
27262143
19.

Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant.

Harper IG, Ali JM, Harper SJ, Wlodek E, Alsughayyir J, Negus MC, Qureshi MS, Motalleb-Zadeh R, Saeb-Parsy K, Bolton EM, Bradley JA, Clatworthy MR, Conlon TM, Pettigrew GJ.

Cell Rep. 2016 May 10;15(6):1214-27. doi: 10.1016/j.celrep.2016.04.009. Epub 2016 Apr 28.

20.

B cells in transplantation.

Dijke EI, Platt JL, Blair P, Clatworthy MR, Patel JK, Kfoury AG, Cascalho M.

J Heart Lung Transplant. 2016 Jun;35(6):704-10. doi: 10.1016/j.healun.2016.01.1232. Epub 2016 Feb 12.

21.

FcγRIIB and autoimmunity.

Espéli M, Smith KG, Clatworthy MR.

Immunol Rev. 2016 Jan;269(1):194-211. doi: 10.1111/imr.12368. Review.

PMID:
26683154
22.

Two-photon microscopy for imaging germinal centers and T follicular helper cells.

Clatworthy MR.

Methods Mol Biol. 2015;1291:63-75. doi: 10.1007/978-1-4939-2498-1_6.

PMID:
25836302
23.

B-cell biomarkers in transplantation--from genes to therapy.

Banham GD, Clatworthy MR.

Tissue Antigens. 2015 Feb;85(2):82-92. doi: 10.1111/tan.12520. Review.

PMID:
25626600
24.

B cell depletion at induction--making bad immunological memory fade?

Clatworthy MR.

Am J Transplant. 2015 Feb;15(2):297-8. doi: 10.1111/ajt.13054. No abstract available.

25.

De-functioning polymorphism in the inhibitory receptor FcγRIIB does not impact upon kidney allograft survival.

Clatworthy MR, Matthews R, Doehler B, Willcocks L, Opelz G, Smith KG.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:159-61. doi: 10.1111/cei.12553. No abstract available.

26.

B cell modulation in transplantation.

Clatworthy MR.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:61-3. doi: 10.1111/cei.12513. No abstract available.

27.

FcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesis.

Clatworthy MR, Harford SK, Mathews RJ, Smith KG.

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17971-6. doi: 10.1073/pnas.1413915111. Epub 2014 Dec 4.

28.

Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes.

Clatworthy MR, Aronin CE, Mathews RJ, Morgan NY, Smith KG, Germain RN.

Nat Med. 2014 Dec;20(12):1458-63. doi: 10.1038/nm.3709. Epub 2014 Nov 10.

29.

Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival.

Clatworthy MR, Matthews RJ, Doehler B, Willcocks LC, Opelz G, Smith KGC.

Transplantation. 2014 Aug 15;98(3):285-291. doi: 10.1097/TP.0000000000000287.

30.

B-cell regulation and its application to transplantation.

Clatworthy MR.

Transpl Int. 2014 Feb;27(2):117-28. doi: 10.1111/tri.12160. Epub 2013 Aug 4. Review.

31.

Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.

Banham G, Prezzi D, Harford S, Taylor CJ, Hamer R, Higgins R, Bradley JA, Clatworthy MR.

Transplantation. 2013 Aug 27;96(4):413-20. doi: 10.1097/TP.0b013e318298dd65.

32.

B cell responses to allograft--more common than we thought?

Clatworthy MR.

Am J Transplant. 2013 Jul;13(7):1629-30. doi: 10.1111/ajt.12309. No abstract available.

33.

The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation.

Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN.

Cell. 2013 Apr 11;153(2):348-61. doi: 10.1016/j.cell.2013.02.054.

34.

Bin2 is a membrane sculpting N-BAR protein that influences leucocyte podosomes, motility and phagocytosis.

Sánchez-Barrena MJ, Vallis Y, Clatworthy MR, Doherty GJ, Veprintsev DB, Evans PR, McMahon HT.

PLoS One. 2012;7(12):e52401. doi: 10.1371/journal.pone.0052401. Epub 2012 Dec 20. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/3bdc487b-5e25-4cd7-a354-b2952eec943d.

35.

Analysis of a wild mouse promoter variant reveals a novel role for FcγRIIb in the control of the germinal center and autoimmunity.

Espéli M, Clatworthy MR, Bökers S, Lawlor KE, Cutler AJ, Köntgen F, Lyons PA, Smith KG.

J Exp Med. 2012 Nov 19;209(12):2307-19. doi: 10.1084/jem.20121752. Epub 2012 Oct 29.

36.

The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases.

Banham-Hall E, Clatworthy MR, Okkenhaug K.

Open Rheumatol J. 2012;6:245-58. doi: 10.2174/1874312901206010245. Epub 2012 Sep 7.

37.

Magnetic resonance imaging with hyperpolarized [1,4-(13)C2]fumarate allows detection of early renal acute tubular necrosis.

Clatworthy MR, Kettunen MI, Hu DE, Mathews RJ, Witney TH, Kennedy BW, Bohndiek SE, Gallagher FA, Jarvis LB, Smith KG, Brindle KM.

Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13374-9. doi: 10.1073/pnas.1205539109. Epub 2012 Jul 26.

38.

Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation.

Jolly EC, Key T, Rasheed H, Morgan H, Butler A, Pritchard N, Taylor CJ, Clatworthy MR.

Am J Transplant. 2012 Oct;12(10):2845-8. doi: 10.1111/j.1600-6143.2012.04172.x. Epub 2012 Jul 3.

39.

Immunotherapy for acute kidney injury.

Berry M, Clatworthy MR.

Immunotherapy. 2012 Mar;4(3):323-34. doi: 10.2217/imt.11.175. Review.

PMID:
22401637
40.

Targeting B cells and antibody in transplantation.

Clatworthy MR.

Am J Transplant. 2011 Jul;11(7):1359-67. doi: 10.1111/j.1600-6143.2011.03554.x. Epub 2011 Jun 10. Review.

41.

Fabry disease: results of the first UK hemodialysis screening study.

Wallin EF, Clatworthy MR, Pritchard NR.

Clin Nephrol. 2011 Jun;75(6):506-10.

PMID:
21612753
42.

The kinetics of donor HLA class I-specific antibody absorption following a combined split liver and kidney transplant.

Key T, Watson CJ, Clatworthy MR, O'Rourke CM, Goodman RS, Taylor CJ, Butler AJ.

NDT Plus. 2010 Dec;3(6):579-81. doi: 10.1093/ndtplus/sfq160. Epub 2010 Sep 6.

43.

The generation and maintenance of serum alloantibody.

Clatworthy MR, Espeli M, Torpey N, Smith KG.

Curr Opin Immunol. 2010 Oct;22(5):669-81. doi: 10.1016/j.coi.2010.08.018. Review.

44.

Donor type does not influence the incidence of major urologic complications after kidney transplantation.

Saeb-Parsy K, Kosmoliaptsis V, Sharples LD, Watson CJ, Clatworthy MR, Taylor CJ, Pettigrew GJ, Bradley JA.

Transplantation. 2010 Nov 27;90(10):1085-90. doi: 10.1097/TP.0b013e3181f7c031.

PMID:
20861803
45.

Biological therapy for lupus nephritis-tribulations and trials.

Smith RM, Clatworthy MR, Jayne DR.

Nat Rev Rheumatol. 2010 Sep;6(9):547-52. doi: 10.1038/nrrheum.2010.117. Epub 2010 Jul 20. Review.

PMID:
20647994
46.

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

Smith KG, Clatworthy MR.

Nat Rev Immunol. 2010 May;10(5):328-43. doi: 10.1038/nri2762. Review. Erratum in: Nat Rev Immunol. 2010 Sep;10(9):674.

47.

FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.

Niederer HA, Clatworthy MR, Willcocks LC, Smith KG.

Ann N Y Acad Sci. 2010 Jan;1183:69-88. doi: 10.1111/j.1749-6632.2009.05132.x. Review.

PMID:
20146709
48.

Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation.

Taylor CJ, Kosmoliaptsis V, Sharples LD, Prezzi D, Morgan CH, Key T, Chaudhry AN, Amin I, Clatworthy MR, Butler AJ, Watson CJ, Bradley JA.

Transplantation. 2010 Jan 27;89(2):185-93. doi: 10.1097/TP.0b013e3181c926f2.

PMID:
20098281
49.

Low-affinity Fcgamma receptors, autoimmunity and infection.

Willcocks LC, Smith KG, Clatworthy MR.

Expert Rev Mol Med. 2009 Aug 13;11:e24. doi: 10.1017/S1462399409001161. Review.

PMID:
19674504
50.

Anti-CTLA-4 (CD 152) monoclonal antibody-induced autoimmune interstitial nephritis.

Jolly EC, Clatworthy MR, Lawrence C, Nathan PD, Farrington K.

NDT Plus. 2009 Aug;2(4):300-2. doi: 10.1093/ndtplus/sfp048. Epub 2009 Apr 28.

Supplemental Content

Loading ...
Support Center